4//SEC Filing
Burgess Julie 4
Accession 0001209191-23-006927
CIK 0001807120other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:43 PM ET
Size
5.6 KB
Accession
0001209191-23-006927
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-01+75,000→ 75,000 totalExercise: $7.97Exp: 2033-01-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001883722
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:43 PM ET
- Size
- 5.6 KB